Freemantle, N., Meneghini, L., Christensen, T., Wolden, M. L., Jendle, J., & Ratner, R. (2013). Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: A meta-analysis of phase 3a trials. Blackwell Publishing Inc.
Chicago Style CitationFreemantle, N., L. Meneghini, T. Christensen, M L. Wolden, J. Jendle, i R. Ratner. Insulin Degludec Improves Health-related Quality of Life (SF-36®) Compared With Insulin Glargine in People With Type 2 Diabetes Starting On Basal Insulin: A Meta-analysis of Phase 3a Trials. Blackwell Publishing Inc, 2013.
Cita MLAFreemantle, N., et al. Insulin Degludec Improves Health-related Quality of Life (SF-36®) Compared With Insulin Glargine in People With Type 2 Diabetes Starting On Basal Insulin: A Meta-analysis of Phase 3a Trials. Blackwell Publishing Inc, 2013.